All cancer research studies involving diagnosis, treatment, prevention and control that have not received traditional peer review for scientific merit must be submitted to the Protocol Review Committee (PRC) for review and approval. The MUSC Institutional Review Board (IRB) requires the PRC approval letter to accompany the initial submission therefore PRC review must occur before a study can be submitted to the IRB. Contact Information Hollings Cancer Center Protocol Review & Monitoring System 86 Jonathan Lucas St. Suite 373 P.O. Box MSC 955 Charleston, SC 29425 | Neal Christiansen, MD, Chair-PRCI Phone: 843-792-7581 E-Mail: hccprms@musc.edu Nester Esnaola, MD, Chair-PRCI Phone: 843-876-4420 E-Mail: hccprms@musc.edu | Philip Hall, PharmD, Chair-PRCII Phone: 843-792-8970 E-Mail: hccprms@musc.edu James Ravenel, MD, Chair-PRCII Phone: 843-792-4363 E-Mail: hccprms@musc.edu | Brigette White, Administrator Phone: 843-792-6231 E-Mail: hccprms@musc.edu | Pat Kelly, Administrative Coordinator Phone: 843-792-9409 E-Mail: hccprms@musc.edu |
Protocol Review Committee Meeting Dates 2009-2010 Meeting Dates Protocol Review Committee Policies (policies currently under revision) (Note: Several of the documents on this page require Adobe@ Acrobat Reader)
Protocol Review Forms
PRC Submission Packet Checklist* Protocol Review Committee Submission Form * Protocol Review Committee Amendment Submission Form * Monthly Accrual Reporting Form* MUSC IRB Guidline for Review of Oncology Trials
*Requires Microsoft Word For Members Only PRC Data Repository
|